Table 3 Most strongly affected cliques by unc-45 RNAi and their characteristics.
Cluster name | Clique position | Best GO-Term | Best PEA-Term | Best TEA-Term | Mean STD | Log10(p) Exp 1 | Log10(p) Exp 2 |
---|---|---|---|---|---|---|---|
nspd-1-nspd-2 | R12 C1 | Structural constituent of cuticle GO:0042302 | Dumpy WBPhenotype:0000583 | WBPaper00037950_coelomocytes_embryo_enriched_WBbt_0005751_570 | 0.38 ± 0.12 | 4.41 | 1.84 |
msp-36-msp-55 | R10 C19 | Lipid storage GO:0019915 | Linker cell migration variant WBPhenotype:0001511 | WBPaper00040420_FLP_enriched_WBbt_0006828_288 | 0.35 ± 0.08 | 1.15 | 2.54 |
msp-63-msp-33 | R9 C14 | Lipid storage GO:0019915 | Linker cell migration variant WBPhenotype:0001511 | WBPaper00040420_FLP_enriched_WBbt_0006828_288 | 0.31 ± 0.09 | 7.92 | 9.08 |
hsp-16.2-F44E5.4_19238 | R12 C4 | Response to heat GO:0009408 | Cadmium response variant WBPhenotype:0001653 | WBPaper00037950_coelomocytes_larva_enriched_WBbt_0005751_229 | 0.29 ± 0.17 | 16.49 | 1.60 |
abu-7-abu-8_22491 | R8 C26 | Response to unfolded protein GO:0006986 | Dauer constitutive WBPhenotype:0000012 | WBPaper00024505_pharyngeal_enriched_WBbt_0003681_329 | 0.25 ± 0.08 | 63.31 | 5.15 |
col-138-col-49 | R9 C23 | Structural constituent of cuticle GO:0042302 | Blistered WBPhenotype:0000025 | WBPaper00037950_coelomocytes_larva_enriched_WBbt_0005751_229 | 0.24 ± 0.22 | 34.90 | 0.93 |
col-117-col-167_1015 | R9 C25 | Structural constituent of cuticle GO:0042302 | Dumpy WBPhenotype:0000583 | WBPaper00037950_germline-precursors_embryo_enriched_WBbt_0006849_974 | 0.24 ± 0.06 | 29.40 | 5.29 |
pqn-54-abu-9 | R6 C11 | Response to unfolded protein GO:0006986 | Shortened life span WBPhenotype:0001171 | WBPaper00024505_pharyngeal_enriched_WBbt_0003681_329 | 0.2 ± 0.03 | 43.57 | 13.10 |
R12E2.14_75-R12E2.15 | R6 C9 | Structural constituent of cuticle GO:0042302 | Dumpy WBPhenotype:0000583 | WBPaper00037950_germline-precursors_embryo_enriched_WBbt_0006849_974 | 0.18 ± 0.08 | 47.12 | 8.99 |
lys-3-tsp-1 | R11 C40 | Carbohydrate metabolic process GO:0005975 | Male nervous system development variant WBPhenotype:0001008 | WBPaper00040420_ALM_PLM_enriched_WBbt_0005406_198 | 0.18 ± 0.22 | 27.93 | 1.06 |
C10C5.3-C10C5.5 | R12 C40 | Oxoacid metabolic process GO:0043436 | Dauer constitutive WBPhenotype:0000012 | WBPaper00037950_pharyngeal-muscle_embryo_enriched_WBbt_0005451_598 | 0.17 ± 0.05 | 4.43 | 2.28 |
F07A5.2-R10E9.2 | R5 C7 | Sodium ion transport GO:0006814 | Nicotine response variant WBPhenotype:0001573 | WBPaper00045521_Spermatogenic_WBbt_0005784_2743 | 0.15 ± 0.04 | 6.82 | 34.38 |
K11C4.1_20445-rnh-1.1 | R8 C22 | Regulation of cell shape GO:0008360 | Fat content increased WBPhenotype:0001184 | WBPaper00045521_Spermatogenic_WBbt_0005784_2743 | 0.14 ± 0.03 | 6.02 | 8.77 |
ssq-2_16507-ssq-3_1032 | R12 C27 | Response to hormone GO:0009725 | Movement variant WBPhenotype:0001206 | WBPaper00026980_intestine_enriched_WBbt_0005772_1970 | 0.13 ± 0 | 1.96 | 2.06 |
col-146-col-133 | R9 C28 | Structural constituent of cuticle GO:0042302 | Dumpy WBPhenotype:0000583 | WBPaper00037950_coelomocytes_larva_enriched_WBbt_0005751_229 | 0.12 ± 0.02 | 11.00 | 2.77 |
F42A9.7-T22B3.3 | R3 C11 | Regulation of cell shape GO:0008360 | Dauer metabolism variant WBPhenotype:0001547 | WBPaper00045521_Spermatogenic_WBbt_0005784_2743 | 0.11 ± 0.03 | 7.97 | 29.43 |
bus-8_3160-K04H4.2_2324 | R9 C2 | Amino sugar metabolic process GO:0006040 | Molt variant WBPhenotype:0002041 | WBPaper00024505_pharyngeal_enriched_WBbt_0003681_329 | 0.11 ± 0.08 | 8.94 | 0.92 |
R12A1.3-M195.2 | R6 C19 | Amino sugar metabolic process GO:0006040 | Dauer constitutive WBPhenotype:0000012 | WBPaper00024505_pharyngeal_enriched_WBbt_0003681_329 | 0.1 ± 0.04 | 6.65 | 3.63 |
T28A11.5-T06C12.14 | R12 C14 | Extracellular region GO:0005576 | Dumpy WBPhenotype:0000583 | WBPaper00037950_excretory-cell_larva_enriched_WBbt_0005812_528 | 0.1 ± 0.05 | 0.71 | 2.01 |
agmo-1_5527-F53B1.4 | R10 C14 | Pyridoxal phosphate binding GO:0030170 | Molt variant WBPhenotype:0002041 | WBPaper00037950_hypodermis_embryo_enriched_WBbt_0005733_734 | 0.1 ± 0.11 | 7.44 | 0.70 |
171971_x_at-D1054.11_184 | R11 C37 | Cell GO:0005623 | Egg laying defective WBPhenotype:0000006 | WBPaper00037950_hypodermis_larva_enriched_WBbt_0005733_1250 | − 0.55 ± 0.09 | 3.70 | 0.66 |
gpd-3_977-aldo-1_21168 | R9 C26 | Glycosyl compound metabolic process GO:1901657 | Fat content reduced WBPhenotype:0001183 | WBPaper00031003_24hr_muscle_enriched_WBbt_0003675_918 | − 0.51 ± 0.01 | 9.02 | 4.52 |
T05E12.6_12439-T05E12.6_12396 | R10 C3 | Lipid catabolic process GO:0016042 | Transgene expression increased WBPhenotype:0001236 | WBPaper00037950_pharyngeal-muscle_embryo_enriched_WBbt_0005451_598 | − 0.29 ± 0.15 | 60.37 | 3.63 |
ZK1053.4-C08F1.6 | R4 C16 | Embryo development GO:0009790 | Embryonic development variant WBPhenotype:0000749 | WBPaper00037950_hypodermis_embryo_enriched_WBbt_0005733_734 | − 0.26 ± 0.12 | 26.51 | 73.26 |
C46C2.5_15926-W03F11.1 | R9 C22 | Carbohydrate binding GO:0030246 | Apoptosis increased WBPhenotype:0000183 | WBPaper00037950_GABAergic-motor-neurons_embryo_enriched_WBbt_0005190_361 | − 0.24 ± 0.02 | 8.57 | 10.00 |
ZC373.2-Y62H9A.6_1596 | R3 C18 | Flavonoid metabolic process GO:0009812 | Cell membrane organization biogenesis variant WBPhenotype:0001982 | WBPaper00037950_dopaminergic-neurons_larva_enriched_WBbt_0006746_1230 | − 0.22 ± 0.03 | 46.68 | 19.54 |
nspc-1_614-nspc-10_22525 | R10 C12 | Extracellular region GO:0005576 | Spermatogenesis variant WBPhenotype:0000670 | WBPaper00037950_coelomocytes_larva_enriched_WBbt_0005751_229 | − 0.21 ± 0.06 | 5.62 | 5.79 |
C46C2.5_15925-F17E9.2 | R10 C8 | Hydrolase activity—acting on glycosyl bonds GO:0016798 | Embryonic development variant WBPhenotype:0000749 | WBPaper00037950_coelomocytes_larva_enriched_WBbt_0005751_229 | − 0.2 ± 0.01 | 6.65 | 6.25 |
C03B1.14-F46C3.2 | R8 C21 | Membrane GO:0016020 | Chemical hypersensitive WBPhenotype:0001918 | WBPaper00037950_intestine_larva_enriched_WBbt_0005772_946 | − 0.19 ± 0 | 9.53 | 10.38 |
fbxc-28-sdz-28 | R7 C8 | Modification-dependent macromolecule catabolic process GO:0043632 | L1 larval development variant WBPhenotype:0000751 | WBPaper00037950_hypodermis_embryo_enriched_WBbt_0005733_734 | − 0.18 ± 0.08 | 10.65 | 27.90 |
fbxb-13-fbxb-24 | R8 C18 | Protein oligomerization GO:0051259 | Cholinergic agonist resistant WBPhenotype:0001578 | WBPaper00024505_pharyngeal_enriched_WBbt_0003681_329 | − 0.17 ± 0.1 | 1.20 | 13.08 |
dsh-1_3575-C40A11.4 | R5 C17 | Protein oligomerization GO:0051259 | Ectopic expression transgene WBPhenotype:0001276 | WBPaper00037950_hypodermis_embryo_enriched_WBbt_0005733_734 | − 0.14 ± 0.07 | 2.78 | 9.72 |
vem-1-ugt-58 | R12 C35 | Oxoacid metabolic process GO:0043436 | Epithelial cell physiology variant WBPhenotype:0000986 | WBPaper00037950_BAG-neuron_embryo_enriched_WBbt_0006825_454 | − 0.14 ± 0.01 | 2.03 | 0.89 |
sdz-10-fbxb-62 | R3 C17 | Glycosylation GO:0070085 | L1 larval development variant WBPhenotype:0000751 | WBPaper00037950_hypodermis_embryo_enriched_WBbt_0005733_734 | − 0.14 ± 0.09 | 2.82 | 41.16 |
Y41D4B.17-K10D11.6 | R12 C32 | Immune system process GO:0002376 | Exploded through vulva WBPhenotype:0000038 | WBPaper00037950_intestine_larva_enriched_WBbt_0005772_946 | − 0.12 ± 0.03 | 0.84 | 0.77 |
fbxb-31-fbxb-119 | R11 C28 | Embryo development GO:0009790 | Transgene expression reduced WBPhenotype:0001278 | WBPaper00040420_FLP_enriched_WBbt_0006828_288 | − 0.12 ± 0.09 | 0.64 | 4.30 |
R03E1.2_7363-ucr-2.1 | R10 C30 | Mitochondrion GO:0005739 | mRNA levels increased WBPhenotype:0000136 | WBPaper00037950_excretory-cell_larva_enriched_WBbt_0005812_528 | − 0.12 ± 0.03 | 0.98 | 2.14 |
C35C5.8_15869-best-1 | R10 C21 | Transmembrane transport GO:0055085 | Fat content increased WBPhenotype:0001184 | WBPaper00037950_excretory-cell_larva_enriched_WBbt_0005812_528 | − 0.12 ± 0.03 | 4.11 | 1.04 |
pek-1_22220-pek-1_33 | R11 C12 | Aging GO:0007568 | Sluggish WBPhenotype:0000646 | WBPaper00037950_GABAergic-motor-neurons_embryo_enriched_WBbt_0005190_361 | − 0.11 ± 0 | 1.85 | 1.69 |
iff-2_18754-rpl-25.1 | R12 C37 | Amide biosynthetic process GO:0043604 | Hermaphrodite fertility reduced WBPhenotype:0001259 | WBPaper00037950_PVD-OLL-neurons_larva_enriched_WBbt_0006831_878 | − 0.11 ± 0.03 | 0.65 | 1.39 |